Steigerwald Gordon & Koch’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$534K Sell
4,437
-125
-3% -$14.4K 0.05% 84
2025
Q4
$480K Sell
4,562
-281
-6% -$26.4K 0.05% 92
2025
Q3
$406K Buy
4,843
+6
+0.1% +$494 0.04% 97
2025
Q2
$383K Sell
4,837
-1,038
-18% -$82.5K 0.04% 90
2025
Q1
$527K Buy
5,875
+63
+1% +$5.88K 0.06% 80
2024
Q4
$578K Sell
5,812
-17
-0.3% -$1.75K 0.07% 80
2024
Q3
$662K Buy
5,829
+643
+12% +$76.4K 0.07% 76
2024
Q2
$642K Buy
5,186
+140
+3% +$18K 0.08% 74
2024
Q1
$666K Buy
5,046
+69
+1% +$8.51K 0.08% 75
2023
Q4
$543K Sell
4,977
-1,117
-18% -$116K 0.07% 79
2023
Q3
$627K Buy
6,094
+283
+5% +$30.5K 0.1% 68
2023
Q2
$671K Buy
5,811
+299
+5% +$33.9K 0.1% 67
2023
Q1
$586K Buy
5,512
+183
+3% +$19.8K 0.09% 72
2022
Q4
$591K Buy
5,329
+323
+6% +$33K 0.09% 69
2022
Q3
$431K Buy
5,006
+17
+0.3% +$1.52K 0.08% 76
2022
Q2
$455K Buy
4,989
+823
+20% +$73K 0.08% 78
2022
Q1
$342K Buy
4,166
+71
+2% +$5.6K 0.05% 90
2021
Q4
$314K Sell
4,095
-227
-5% -$18.1K 0.05% 89
2021
Q3
$325K Buy
4,322
+76
+2% +$5.78K 0.05% 90
2021
Q2
$330K Sell
4,246
-253
-6% -$18.8K 0.05% 88
2021
Q1
$331K Buy
4,499
+157
+4% +$11.6K 0.06% 86
2020
Q4
$339K Buy
4,342
+826
+23% +$63.2K 0.07% 82
2020
Q3
$278K Sell
3,516
-51
-1% -$4K 0.07% 84
2020
Q2
$263K Buy
3,567
+171
+5% +$12.9K 0.07% 80
2020
Q1
$249K Sell
3,396
-77
-2% -$6.05K 0.08% 75
2019
Q4
$301K Buy
3,473
+680
+24% +$55.9K 0.07% 77
2019
Q3
$224K Buy
2,793
+1
+0% +$80 0.06% 79
2019
Q2
$223K Buy
+2,792
New +$214K 0.06% 77
2017
Q3
Sell
-3,703
Closed -$226K 91
2017
Q2
$226K Buy
+3,703
New +$225K 0.06% 79

Other funds holding MRK

Steigerwald Gordon & Koch's MRK Position: Q1 2026 in Review

Steigerwald Gordon & Koch reduced its Merck (MRK) stake by 2.7% in Q1 2026, selling an estimated $14.4K and leaving 4,437 shares worth $534K. The position accounts for 0.05% of the portfolio, ranked #84.

Steigerwald Gordon & Koch first reported a position in MRK in Q2 2017 and has held it in 29 quarters since. The position peaked at $671K in Q2 2023. 3,774 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Steigerwald Gordon & Koch held 4,437 shares of Merck worth $534K as of Q1 2026.
  • Steigerwald Gordon & Koch sold 125 Merck shares in Q1 2026, an estimated $14.4K.
  • Merck made up 0.05% of Steigerwald Gordon & Koch's portfolio in Q1 2026, its #84 holding.
  • Steigerwald Gordon & Koch first reported a position in Merck in Q2 2017 and has held it in 29 quarters since.
  • Steigerwald Gordon & Koch's Merck position peaked at $671K in Q2 2023.
  • 3,774 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q1 2026, filed 28 Apr 2026.